Far Northern Resources Limited (FNR.AX)
AUD 0.11
(-21.43%)
AUD 0.11
(-21.43%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | - | 27 Thousand | - | - |
| Cost of Revenue | 106.69 Thousand | - | 66.4 Thousand | 3199.00 |
| Gross Profit | -106.69 Thousand | 27 Thousand | -66.4 Thousand | -3199.00 |
| Operating Expenses | 799.22 Thousand | 367.87 Thousand | 46.45 Thousand | 305.91 Thousand |
| Selling, General and Administrative Expenses | 799.22 Thousand | 367.87 Thousand | 46.45 Thousand | 305.91 Thousand |
| Research and Development Expenses | - | - | - | - |
| Other Expenses | - | - | - | - |
| Cost and Expenses | 905.92 Thousand | 433.47 Thousand | 112.85 Thousand | 309.1 Thousand |
| Operating Income | -905.92 Thousand | -406.48 Thousand | -112.85 Thousand | -309.11 Thousand |
| Interest Expense | 1716.00 | - | - | - |
| Income Tax Expense | -169.87 Thousand | -11.48 Thousand | -21.13 Thousand | -22.33 Thousand |
| Earnings before Tax | -1.07 Million | -406.47 Thousand | -112.85 Thousand | -309.1 Thousand |
| Net Income | -1.07 Million | -394.99 Thousand | -91.71 Thousand | -286.77 Thousand |
| Earnings Per Share Basic | -0.04 | -0.01 | -0.00 | -0.01 |
| Earnings Per Share Diluted | -0.04 | -0.01 | -0.00 | -0.01 |
| Weighted Average Shares Outstanding | 30 Million | 30 Million | 30 Million | 30 Million |
| Weighted Average Shares Outstanding (Diluted) | 30 Million | 30 Million | 30 Million | 30 Million |
| Gross Margin | - | 1.00 | - | - |
| EBIT Margin | - | -12.63 | - | - |
| Profit Margin | - | -14.63 | - | - |
| EBITDA | -969.1 Thousand | -340.87 Thousand | -46.45 Thousand | -305.91 Thousand |
| Earnings Before Tax Margin | - | -15.05 | - | - |
| Breakdown | 2023 Q4 | 2022 FY | 2021 FY | 2020 FY |
|---|---|---|---|---|
| Revenue | - | 27 Thousand | - | - |
| Cost of Revenue | 32.5 Thousand | - | 66.4 Thousand | 3199.00 |
| Gross Profit | -32.5 Thousand | 27 Thousand | -66.4 Thousand | -3199.00 |
| Operating Expenses | 253.49 Thousand | 367.87 Thousand | 46.45 Thousand | 305.91 Thousand |
| Selling, General and Administrative Expenses | 253.49 Thousand | - | - | - |
| Research and Development Expenses | - | - | - | - |
| Other Expenses | - | - | - | - |
| Cost and Expenses | 285.99 Thousand | 433.47 Thousand | 112.85 Thousand | 309.1 Thousand |
| Operating Income | -286 Thousand | -406.48 Thousand | -112.85 Thousand | -309.11 Thousand |
| Interest Expense | - | - | - | - |
| Income Tax Expense | -8439.00 | -11.48 Thousand | -21.13 Thousand | -22.33 Thousand |
| Earnings before Tax | -285.99 Thousand | -406.47 Thousand | -112.85 Thousand | -309.1 Thousand |
| Net Income | -277.55 Thousand | -394.99 Thousand | -91.71 Thousand | -286.77 Thousand |
| Earnings Per Share Basic | -0.01 | - | - | - |
| Earnings Per Share Diluted | -0.01 | - | - | - |
| Weighted Average Shares Outstanding | 30 Million | 30 Million | 30 Million | 30 Million |
| Weighted Average Shares Outstanding (Diluted) | 30 Million | 30 Million | 30 Million | 30 Million |
| Gross Margin | - | 1.00 | - | - |
| EBIT Margin | - | - | - | - |
| Profit Margin | - | -14.63 | - | - |
| EBITDA | -253.49 Thousand | - | - | - |
| Earnings Before Tax Margin | - | -15.05 | - | - |
MITUF
JBCHEPHARM
RFG
6827
300133
ROX